Asiaticoside enhances the effect of propofol on the invasion, ferroptosis and immune escape of bladder cancer

IF 3.5 4区 医学 Q2 CHEMISTRY, MEDICINAL
Ming Jin, Kun He, Shuqing Zhen, Yanqiao Wang, Huifang Guo, Hongxia Shen, Fumin Ping
{"title":"Asiaticoside enhances the effect of propofol on the invasion, ferroptosis and immune escape of bladder cancer","authors":"Ming Jin,&nbsp;Kun He,&nbsp;Shuqing Zhen,&nbsp;Yanqiao Wang,&nbsp;Huifang Guo,&nbsp;Hongxia Shen,&nbsp;Fumin Ping","doi":"10.1002/ddr.22242","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n <p>Bladder cancer is a highly prevalent malignancy. Asiaticoside (AC), a triterpenoid derivative, exhibits antitumor effect on different tumors. This study aimed to explore the role and mechanism of AC on bladder cancer. J82 and T24 cells were treated with AC and/or propofol, and nude mice were subcutaneously administrated with T24 cells. The effect and mechanism of AC and/or propofol were explored by cell counting kit-8, transwell, flow cytometry, enzyme-linked immunosorbent assay, immunohistochemistry and western blot assays both in vitro and in vivo. Cell viability of J82 and T24 cells was inhibited by AC with a IC50 value of 2.43 μM and 2.16 μM, and by propofol with a IC50 value of 42.51 μM and 48.37 μM, respectively. AC or propofol alone decreased cell proliferation, invasion, and immune escape with the increased ferroptosis, as well as downregulating the level of the PI3K/AKT pathway in both animal and cell experiments. The effect of propofol on the above-mentioned indicators was further enhanced with the co-treatment of AC in vitro and in vivo. Taken together, AC promoted the ameliorative effect of propofol on bladder cancer involved in PI3K/AKT pathway.</p>\n </section>\n </div>","PeriodicalId":11291,"journal":{"name":"Drug Development Research","volume":"85 6","pages":""},"PeriodicalIF":3.5000,"publicationDate":"2024-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Development Research","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ddr.22242","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0

Abstract

Bladder cancer is a highly prevalent malignancy. Asiaticoside (AC), a triterpenoid derivative, exhibits antitumor effect on different tumors. This study aimed to explore the role and mechanism of AC on bladder cancer. J82 and T24 cells were treated with AC and/or propofol, and nude mice were subcutaneously administrated with T24 cells. The effect and mechanism of AC and/or propofol were explored by cell counting kit-8, transwell, flow cytometry, enzyme-linked immunosorbent assay, immunohistochemistry and western blot assays both in vitro and in vivo. Cell viability of J82 and T24 cells was inhibited by AC with a IC50 value of 2.43 μM and 2.16 μM, and by propofol with a IC50 value of 42.51 μM and 48.37 μM, respectively. AC or propofol alone decreased cell proliferation, invasion, and immune escape with the increased ferroptosis, as well as downregulating the level of the PI3K/AKT pathway in both animal and cell experiments. The effect of propofol on the above-mentioned indicators was further enhanced with the co-treatment of AC in vitro and in vivo. Taken together, AC promoted the ameliorative effect of propofol on bladder cancer involved in PI3K/AKT pathway.

Asiaticoside能增强异丙酚对膀胱癌的侵袭、铁凋亡和免疫逃逸的作用。
膀胱癌是一种高发的恶性肿瘤。Asiaticoside(AC)是一种三萜类衍生物,对不同肿瘤具有抗肿瘤作用。本研究旨在探讨AC对膀胱癌的作用和机制。用AC和/或丙泊酚处理J82和T24细胞,并给裸鼠皮下注射T24细胞。通过细胞计数试剂盒-8、transwell、流式细胞术、酶联免疫吸附试验、免疫组织化学和Western blot等方法,探讨了AC和/或异丙酚在体内外对膀胱癌的作用和机制。AC 抑制 J82 和 T24 细胞活力的 IC50 值分别为 2.43 μM 和 2.16 μM,异丙酚抑制 J82 和 T24 细胞活力的 IC50 值分别为 42.51 μM 和 48.37 μM。在动物实验和细胞实验中,单用 AC 或丙泊酚都能减少细胞增殖、侵袭和免疫逃逸,增加铁变态反应,并下调 PI3K/AKT 通路的水平。在体外和体内联合使用 AC 后,异丙酚对上述指标的影响进一步增强。综上所述,AC 可促进异丙酚对涉及 PI3K/AKT 通路的膀胱癌的改善作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.40
自引率
2.60%
发文量
104
审稿时长
6-12 weeks
期刊介绍: Drug Development Research focuses on research topics related to the discovery and development of new therapeutic entities. The journal publishes original research articles on medicinal chemistry, pharmacology, biotechnology and biopharmaceuticals, toxicology, and drug delivery, formulation, and pharmacokinetics. The journal welcomes manuscripts on new compounds and technologies in all areas focused on human therapeutics, as well as global management, health care policy, and regulatory issues involving the drug discovery and development process. In addition to full-length articles, Drug Development Research publishes Brief Reports on important and timely new research findings, as well as in-depth review articles. The journal also features periodic special thematic issues devoted to specific compound classes, new technologies, and broad aspects of drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信